Previous 10 | Next 10 |
home / stock / tlt / tlt articles
Risk sentiment rebounded during midday Wednesday trading in New York as stocks surged, driven by a retreat in Treasury yields after several session...
The negative sentiment that has enveloped the equity market in recent sessions persists amid a lack of clarity regarding the interest rate trajecto...
It’s a red Tuesday for the U.S. stock market, with all major indices on Wall Street plummeting by over 1% during midday trading in New York. ...
On Friday, U.S. stocks displayed negative performance and were poised to conclude the month with declines across various sectors except for energy....
Markets are bouncing back after days of pronounced volatility, aided by the slowdown in Treasury yields and Thursday’s dip in the value of th...
It’s another red session for Wall Street on Wednesday, with signs of a bearish trend becoming increasingly apparent. The drivers behind the w...
Stocks are deep in the red during midday trading on Tuesday, with September proving to be a negative month for Wall Street, as has traditionally be...
In midday trading on Monday, U.S. stocks attempted a rebound following sharp losses experienced Friday. The bond market continued its downward spir...
Wall Street is in the green on Friday, showing gains across major U.S. equity indices following significant losses on Thursday. Notably, the techno...
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / July 8, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDCs ...
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...